info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Angioplasty Balloons Market Size, Industry Trends & Forecast

Angioplasty Balloons Market By Product Type (Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon), By Application (Coronary, Peripheral), By End-user (Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories), By Geography, Size, Trends, Industry Growth Report, Forecast, 2021-2030

Published On: May-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 40189351

Report DescriptionTable of Contents

Industry Report and Statistics

The global angioplasty balloons market will witness a robust CAGR of 4.10%, valued at $2.60 billion in 2021, expected to appreciate and reach $3.73 billion by 2030, confirms Strategic Market Research. North America significantly held the maximum share of the market in 2020, and it is expected to continue its sheer dominance throughout the forecasted period. Angioplasty, also termed balloon angioplasty & percutaneous transluminal angioplasty, is considered a MI (minimally invasive) endovascular procedure. It is used to widen narrowed or obstructed arteries or veins to treat arterial atherosclerosis. A balloon-tipped catheter is implemented in angioplasty to clear a blocked blood vessel and improve blood flow throughout the human body. The angioplasty technique is primarily performed in a cardiac attack. The Global Health and Wellness Report of 2018 confirmed that approximately 40% of the adult population in the United States had been diagnosed with cardiovascular disease. Also, according to the Foundation de France, one out of every three adults in France is at risk of developing cardiovascular disease. In France, around 130,000 heart attacks and 120,000 strokes occur each year, which in turn is increasing the demand for Angioplasty balloons globally, thereby driving its industry growth.

global angioplasty balloons market by share 2020-2030

Market Drivers - An Increasing Number of Cardiovascular Diseases, the Impact of Covid 19, Rising Geriatric Population

  • According to the World Health Organization (WHO), the United States has roughly 8 million people with peripheral artery disease. Coronary heart disease is the major cause of mortality in the country, accounting for over half of fatalities. Over the predicted period, the prevalence of these disorders is expected to rise. Furthermore, a rising elderly population with heart disease and diabetes is predicted to drive up the demand for angioplasty balloon catheters throughout the forecasted period. Also, as per a survey performed by the Health Protection Agency, around 610,000 individuals die in the U.S. every year due to cardiac abnormalities, with the number continuing to rise in due course of time. 

 

  • According to the World Aging Population Report, the worldwide population of netizens aged 65 or more was estimated to be about 702.9 million in 2019, which is projected to rise up to 1548.9 million by 2050. As the senior population grows, chronic illnesses are predicted to rise, leading to more hospitalizations and surgeries.

 

  • Furthermore, the increasing cases of Atherosclerosis and Carotid artery injury are increasing the demand for Percutaneous Transluminal Coronary Angioplasty, Coronary artery stents, Brachytherapy, Carotid artery angioplasty, Cerebral angioplasty, heart balloon angioplasty, and Cardiac Catheterization, hence driving the overall angioplasty balloons market growth.

 

Restraints - Low Awareness in Underdeveloped Countries

  • In developing nations, a lack of knowledge will hinder market expansion. In addition, the industry will likely face challenges due to the scarcity of experienced medical personnel, high surgical procedure costs, and a lack of favorable reimbursement policies in emerging and undeveloped nations. 

 

  • Furthermore, increased product recalls and clinical risks or consequences of surgical procedures may stifle the industry's growth.

 

Opportunities - Increasing Prevalence of Target Illnesses

  • One of the major reasons driving the market expansion is an increase in the prevalence of target diseases. According to the WHO (World Health Organization), cardiovascular diseases impact 485.6 million people worldwide, with 17.9 million deaths. This figure represents 35% of all fatalities worldwide. Furthermore, heart attacks account for 85 percent of all fatalities associated with cardiovascular disease. Also, increasing awareness of the minimally invasive surgical procedures, Balloon angioplasty success rate, the launch of innovative products, and the rising prevalence of coronary and peripheral artery diseases in developing countries are expected to cater to ample opportunities for industry growth in the future.

 

  • Furthermore, the rise in usage of drug-eluting stents and the untapped potential of emerging markets contribute to lucrative market growth opportunities.

angioplasty balloons market by application 2020-2030

Market Analysis Of Different Segments Covered in the Report

Based on the Product Type

  • Normal Balloons

  • Scoring Balloons

  • Drug-eluting balloons

  • Cutting balloon

 

Based on Application

  • Coronary 

  • Peripheral 

 

Based on End-user

  • Ambulatory Surgery Centres (ASCs)

  • Hospitals

  • Catheterization Laboratories 

 

Regional Coverage Analysis

North America

  • The U.S.

  • Canada

  • Mexico

  • Rest of North America

 

Europe

  • France

  • Germany

  • U.K

  • Spain

  • Italy

  • Rest of Europe

 

Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • Rest of APAC

 

LAMEA

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

angioplasty balloons market by end user 2020-2030

 

Product Type Analysis & Insights

The Normal Balloons segment held the largest industry share in 2020 due to the lower cost of these devices, supportive government laws and approval processes, and attractive reimbursement policies. However, the fastest-growing segment is expected to be the Drug-Eluting Balloons (DEBs). Favorable reimbursement procedures resulted in an increase in DEB sales, which is expected to continue in the foreseeable years. The launch of new devices, the benefits of DEBs over ordinary balloons, and the cheaper cost of DEBs compared to stents contribute to the increasing growth of this segment.

 

Application Analysis & Insights

Based on the Application, the Coronary segment held the largest angioplasty balloons market share in 2020 because of the high prevalence of coronary artery disease, one of the prominent types of heart disease. According to the CDC, these diseases cause approximately 370,000 deaths per year globally. Also, the World Health Organization asserted that Heart disease had remained the leading cause of death worldwide for the last 20 years. The number of fatalities from heart diseases increased from 2 Mn in 2000 to approximately 9 million in 2019. On the other hand, because of the increasing number of approvals for innovative drugs and devices, Peripheral artery diseases are expected to be the fastest-growing segment in the upcoming years. Furthermore, increased awareness of disorders affecting the peripheral arteries and the availability of improved products are predicted to propel the market forward. The CDC has announced that approximately 6.5 million people aged 40 years or older in the United States suffer from PAD. 

 

End-User Analysis & Insights

Based on the End-user, the Hospital segment is expected to have the largest industry share in 2020. Advanced healthcare infrastructure, rising availability of skilled healthcare professionals, and affordability drive this segment's supremacy. According to a report published by the Advanced Medical Technology Association (AdvaMed), India's move to cap the maximum prices of various cardiovascular surgical instruments has reduced angioplasty procedure costs in tier 1 by up to 18 percent.

 

Region Analysis & Insights

North America held the maximum share. The region's major drivers include the prevalence of significant players, a shift in FDA policy in the United States, and an increase in the frequency of percutaneous coronary procedures. The American College of Cardiology confirmed that around 1.2 million angioplasties are done yearly in the United States. Due to the rising healthcare spending and excellent government support, the Asia Pacific is likely to be the most attractive and fastest-growing geographical market throughout the estimated period.

 

Angioplasty Balloons Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 2.60 billion

The revenue forecast in 2030

USD 3.73 billion

Growth rate

CAGR of approximately 4.10%

The base year for estimation

2021

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Product, By Application, By End-user, By Region

By Product

Normal Balloons, Scoring Balloons, Drug-eluting balloons, Cutting balloon

By Application

Coronary, Peripheral 

By End-user

Ambulatory Surgery Centres (ASCs), Hospitals, Catheterization Laboratories

By Region

Asia Pacific, North America, Europe, LAMEA

Country Scope

U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc.

Company Usability Profiles

Spectranetics Corp., Becton, Medtronic PLC, Boston Scientific Corporation; Cook Medical, Inc., Dickinson and Company (C. R. Bard, Inc.), Cardinal Health (Cordis), ENDOCOR GmbH, Johnson & Johnson, Abbott Laboratories, etc.

 

Angioplasty Balloons Market Competitive Landscape Analysis

The competitive landscape analysis provides information about the crucial competitors prevailing in the global environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc.

 

angioplasty balloons market by region 2020-2030

 

Recent Developments

  • In August 2021, by collaborating with the National University of Ireland Galway (NUI Galway), SINOMED, a prominent global medical device company, announced the first commercial implantation of the HT Supreme Drug-Eluting Stent (DES) at University Hospital Galway, thereby promoting and advancing the European launch.

 

  • In January 2021, The JADE 0.014", 0.018", and 0.035" OTW non-compliant peripheral balloon dilatation catheter series from OrbusNeich Medical Co. Ltd received authorization from the US Food and Drug Administration (FDA). The JADE OTW Balloon Dilatation Catheter for Percutaneous Transluminal Angioplasty (PTA) is an over-the-wire balloon catheter for percutaneous transluminal angioplasty of obstructed native arteries and synthetic arteriovenous dialysis fistulae.

 

  • In November 2020, InfinityAngioplasty Balloon Co. announced the completion of a First-in-Human clinical study for their novel angioplasty balloon platform, the Infinity Angioplasty Balloon Catheter. 

 

  • In June 2020, the FDA approved the device for PTA treatment of peripheral artery diseases in peripheral vessels such as the iliac, femoral, popliteal, and infra-popliteal arteries and the treatment of A.V. dialysis fistulae.

 

Frequently Asked Question About This Report

b: The global angioplasty balloons market is expected to grow at a compound annual growth rate (CAGR) of 4.10% from 2021 to 2030 to reach USD 3.73 billion by 2030.

b: Balloon angioplasty is a procedure used to unblock blocked or constricted arteries. It entails placing a catheter with a balloon attached to an artery. The balloon is inflated where plaque deposits have blocked or restricted blood flow.

b: In Gruentzigs time, the first angioplasty balloons were manufactured of flexible PVC (polyvinyl chloride). Cross-linked polyethylene was employed in the next generation of balloon technology. Polyethene terephthalate (PET) or nylon are the most common materials used in the twenty-first century.

b: Balloon angioplasty surgery is a procedure in which interventional cardiologists open constricted arteries. They employ a catheter, which is a long, thin tube with a tiny balloon at the tip. They inflate the balloon (using an angioplasty balloon inflation device), flattening or compressing the plaque against the arterial wall at the obstruction site.

b: The key segments inculcated in the angioplasty balloons market are Product Type, Application, End-users, and Region.

b: The global angioplasty balloons market share was around USD 2.60 Billion 2021, and it is forecasted to grow at a CAGR of 4.10% from 2021 to 2030. As a result, the global angioplasty balloons market Forecast suggests reaching around USD 3.73 Billion by 2030.

b: The global angioplasty balloons market size was around $2.60 Billion in 2021 and is predicted to reach $3.73 Billion in 2030.

Sources

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000558

https://www.fondationdefrance.org/en/cardiovascular-disease

https://www.cdc.gov/heartdisease/facts.htm

https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf